ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,961Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 290

$724K Total Retail Price of All Prescriptions

Rank: 6 out of 290

859 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 859 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 8,844 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
CARVEDILOL 898 664 1 2
WARFARIN SODIUM 701 631 2 7
LISINOPRIL 681 519 3 1
SOTALOL 545 489 4 21
AMLODIPINE BESYLATE 516 458 5 6
MULTAQ 319 304 10 6 36
FUROSEMIDE 317 254 7 4
ISOSORBIDE MONONITRATE ER 307 204 8 9
RANEXA 284 177 9 38
DIGOXIN 260 222 10 13
BYSTOLIC 246 212 11 30
METOPROLOL SUCCINATE 236 221 12 8
LOSARTAN POTASSIUM 236 219 12 15
FAMOTIDINE 232 165 14 73
METOPROLOL TARTRATE 231 208 15 3
POTASSIUM CHLORIDE 228 184 16 14
PRAVASTATIN SODIUM 221 186 17 17
HYDRALAZINE HCL 221 178 17 32
PRADAXA 216 200 19 25
PLAVIX 215 138 20 12
SIMVASTATIN 205 150 21 5
CLOPIDOGREL 196 135 22 11
RAMIPRIL 182 165 23 28
HYDROCHLOROTHIAZIDE 153 136 24 19
NIASPAN 136 71 25 34
ATORVASTATIN CALCIUM 123 83 26 10
CRESTOR 123 99 26 16
NITROSTAT 115 62 28 24
TIKOSYN 107 96 29 93
DILTIAZEM 24HR CD 102 81 30 23
SOTALOL AF 100 88 10 31 148
AMIODARONE HCL 89 74 32 22
EFFIENT 81 58 33 39
PROPAFENONE HCL 81 62 33 52
KLOR-CON M20 76 37 35 35
LOVASTATIN 76 65 35 27
DIOVAN 70 70 37 26
EPLERENONE 67 60 38 170
JANTOVEN 67 21 38 71
XARELTO 59 50 40 79
BENICAR 58 52 41 99
TORSEMIDE 58 40 41 45
FLECAINIDE ACETATE 57 47 43 37
ZETIA 55 50 44 33
TRICOR 53 47 45 65
DILTIAZEM ER 50 38 46 43
SPIRONOLACTONE 50 32 46 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.